These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Molecular and pharmacological characterization of genes encoding urotensin-II peptides and their cognate G-protein-coupled receptors from the mouse and monkey. Elshourbagy NA; Douglas SA; Shabon U; Harrison S; Duddy G; Sechler JL; Ao Z; Maleeff BE; Naselsky D; Disa J; Aiyar NV Br J Pharmacol; 2002 May; 136(1):9-22. PubMed ID: 11976263 [TBL] [Abstract][Full Text] [Related]
8. Differential agonistic and antagonistic effects of the urotensin-II ligand SB-710411 at rodent and primate UT receptors. Behm DJ; Herold CL; Camarda V; Aiyar NV; Douglas SA Eur J Pharmacol; 2004 May; 492(2-3):113-6. PubMed ID: 15178353 [TBL] [Abstract][Full Text] [Related]
9. Role of urotensin II and its receptor in health and disease. McDonald J; Batuwangala M; Lambert DG J Anesth; 2007; 21(3):378-89. PubMed ID: 17680191 [TBL] [Abstract][Full Text] [Related]
10. Cell and tissue responses of a range of Urotensin II analogs at cloned and native urotensin II receptors. Evidence for coupling promiscuity. Song W; McDonald J; Camarda V; Calo G; Guerrini R; Marzola E; Thompson JP; Rowbotham DJ; Lambert DG Naunyn Schmiedebergs Arch Pharmacol; 2006 May; 373(2):148-57. PubMed ID: 16596397 [TBL] [Abstract][Full Text] [Related]
11. Urotensin II receptor antagonist reduces hepatic resistance and portal pressure through enhanced eNOS-dependent HSC vasodilatation in CCl Zhang R; Chen J; Liu D; Wang Y Front Med; 2019 Jun; 13(3):398-408. PubMed ID: 30820806 [TBL] [Abstract][Full Text] [Related]
12. Urotensin-II and UII-receptor expression and function in the rat adrenal cortex. Albertin G; Casale V; Ziolkowska A; Spinazzi R; Malendowicz LK; Rossi GP; Nussdorfer GG Int J Mol Med; 2006 Jun; 17(6):1111-5. PubMed ID: 16685423 [TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics and pharmacodynamics of the urotensin-II receptor antagonist palosuran in healthy male subjects. Sidharta PN; van Giersbergen PL; Dingemanse J J Clin Pharmacol; 2009 Oct; 49(10):1168-75. PubMed ID: 19625629 [TBL] [Abstract][Full Text] [Related]
15. Ligand-supported purification of the urotensin-II receptor. Du AT; Onan D; Dinh DT; Lew MJ; Ziogas J; Aguilar MI; Pattenden LK; Thomas WG Mol Pharmacol; 2010 Oct; 78(4):639-47. PubMed ID: 20647393 [TBL] [Abstract][Full Text] [Related]
16. The urotensin-II receptor antagonist palosuran improves pancreatic and renal function in diabetic rats. Clozel M; Hess P; Qiu C; Ding SS; Rey M J Pharmacol Exp Ther; 2006 Mar; 316(3):1115-21. PubMed ID: 16267137 [TBL] [Abstract][Full Text] [Related]
17. Evidence for endogenous urotensin-II as an inhibitor of insulin secretion. Study in the perfused rat pancreas. Marco J; Egido EM; Hernández R; Silvestre RA Peptides; 2008 May; 29(5):852-8. PubMed ID: 17931748 [TBL] [Abstract][Full Text] [Related]
18. Cloning and pharmacological characterization of the cat urotensin-II receptor (UT). Aiyar N; Johns DG; Ao Z; Disa J; Behm DJ; Foley JJ; Buckley PT; Sarau HM; van-der-Keyl HK; Elshourbagy NA; Douglas SA Biochem Pharmacol; 2005 Apr; 69(7):1069-79. PubMed ID: 15763543 [TBL] [Abstract][Full Text] [Related]